Predictors for the progression of hepatic cirrhosis to hepatocellular carcinoma under long-term antiviral therapy

Patients with HBV-related cirrhosis have the potential for progression to HCC even under long-term NA therapy. The LSM value and the serum PIVKA-II level are significant predictors of HCC occurrence.